Survey Supports Meniett Therapy for Management of Meniere’s Disease

Results of a survey published in the August 2007 issue of Otology & Neurotology indicate that the Meniett Low Pressure Pulse Generator, manufactured by Medtronic, is the preferred treatment method after diet modification for patients diagnosed with Ménière’s disease in their only functional ear, the company announced.

The survey was conducted among a nonrandom sample of clinically active members of the American Otological Society and the American Neurotology Society, it added.

Dietary modification was recommended as first-line therapy by 99 percent of the survey respondent, Medtronic said. When asked what they would offer if initial treatment failed, respondents chose the Meniett device first and most frequently over therapies such as intratympanic corticosteroids, endolymphatic sac mastoid shunt, intratympanic gentamicin perfusion and endolymphatic sac vein decompression.